Portage Biotech Balance Sheet Health
Financial Health criteria checks 4/6
Portage Biotech has a total shareholder equity of $1.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $5.2M and $3.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.33m |
| Equity | US$1.81m |
| Total liabilities | US$3.43m |
| Total assets | US$5.24m |
Financial Position Analysis
Short Term Liabilities: PRTG's short term assets ($5.2M) exceed its short term liabilities ($3.0M).
Long Term Liabilities: PRTG's short term assets ($5.2M) exceed its long term liabilities ($422.0K).
Debt to Equity History and Analysis
Debt Level: PRTG is debt free.
Reducing Debt: PRTG has no debt compared to 5 years ago when its debt to equity ratio was 2.5%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PRTG has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: PRTG has less than a year of cash runway if free cash flow continues to reduce at historical rates of 38.7% each year